pfizer inc. (pfe) is a leading global biopharmaceutical company based in new york. the company’s market capitalization was $280.1 billion, as of market close on aug. 20, 2021. pfizer’s best-selling drugs in fy 2020 were: prevnar 13/prevenar 13, a pneumococcal disease vaccine, which generated $5.9 billion in revenue; ibrance, used to treat certain breast cancers, which brought in $5.4 billion; and eliquis, used to treat nonvalvular atrial fibrillation, deep vein thrombosis, and pulmonary embolism, and which generated $4.9 billion several other large, global drug manufacturers present pfizer with significant competition. other top-selling medicines in fy 2020 include: neuroscience drug ocrevus, which brought in $4.7 billion in revenue; and oncology drug perjeta, which generated $4.3 billion. eli lilly’s top-selling drug in fy 2020 was trulicity, which is used to treat type 2 diabetes as well as reduce the risk of significant adverse cardiovascular events.
other top-selling medicines in fy 2020 include: diabetes drug humalog, which generated $2.6 billion in revenue; and oncology drug alimta, which brought in $2.3 billion. abbvie’s top-selling drug in fy 2020 was humira, which is a biologic therapy used to treat a number of autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, adult crohn’s disease, and others. other top-selling drugs in fy 2020 include: neuroscience drug gilenya, which generated revenue of $3.0 billion; and cardiovascular, renal, and metabolism drug entresto, which brought in $2.5 billion in revenue. merck’s top-selling drug in fy 2020 was keytruda, which is used to treat patients with a range of different types of cancer, such as cervical cancer, classical hodgkin lymphoma, certain lung cancers, and numerous others. other top-selling drugs in fy 2020 include: diabetes drugs januvia/janumet, which brought in $5.3 billion of revenue; and human papillomavirus vaccines gardasil/gardasil 9, which generated $3.9 billion in revenue.
pfizer inc. is engaged in the discovery, development, and manufacturing of healthcare products. pfizer spends close to $8 billion annually on research and development, a leading amount in the industry. pfizer first began in 1849, when two german-american entrepreneurs first started the company as a fine chemicals business. pfizer’s work in developing and mass-producing a vaccine for the covid-19 virus is unparalleled. they have also noted that pfizer benefited from billions of dollars in federal funding to mass-produce the vaccine immediately upon approval. in response to the pandemic, pfizer partnered with biontech in april 2020 to develop a vaccine for covid-19.
hospitals in the u.k. have gathered real-world evidence which seems to show that a single dose of the pfizer vaccine gives a four-fold reduction in the number of asymptomatic covid-19 infections. resulted in a loss of diversification for the company. this also led to the company dropping a few spots in fortune 500 global rankings. severe allergy-like reactions were observed in people receiving the covid-19 vaccine produced by pfizer and biontech. its work in developing and manufacturing a covid-19 vaccine is also a major factor in determining the company’s performance in the last year. while it has had its share of production issues, pfizer’s response to the pandemic has been unprecedented in its speed.
pfizer’s main competitors are roche holding ag, eli lilly and co., abbvie inc., novartis ag, and merck & co. roche holding ag (rhhby). market cap: $344.4 pfizer swot analysis, competitors & usp ; below are the top 9 competitors of pfizer: 1. abbott laboratories. 2. amgen. 3. astrazeneca. 4. bristol swot analysis of pfizer focuses on strengths, weaknesses, opportunities, and threats. pfizer is one of the largest medicine and vaccine, pfizer subsidiaries, pfizer subsidiaries, pfizer competitive advantage, pfizer swot analysis 2019, pfizer company analysis.
this pfizer swot analysis highlights the company’s strengths and weaknesses, as well as its potential opportunities and threats. comparing the results to its competitors, pfizer inc reported total revenue increase in the by 98.62 % year on year. the sales growth was above company snapshot – pfizer inc. □ investment thesis – what is driving our optimism? □ swot analysis. □ valuation – financial statements and model outputs., pfizer swot analysis 2020, pfizer swot analysis 2022, pfizer market share 2020, opportunities for pfizer, pfizer vaccine competitors, pfizer swot analysis 2021, pfizer weaknesses swot, pfizer pestle analysis, pfizer weaknesses 2021, pfizer strengths. who is pfizer biggest competitor? what is the weakness of pfizer? who is the number 1 pharmaceutical company? what are the strengths of pfizer?
When you try to get related information on pfizer competitors analysis, you may look for related areas. pfizer subsidiaries, pfizer competitive advantage, pfizer swot analysis 2019, pfizer company analysis, pfizer swot analysis 2020, pfizer swot analysis 2022, pfizer market share 2020, opportunities for pfizer, pfizer vaccine competitors, pfizer swot analysis 2021, pfizer weaknesses swot, pfizer pestle analysis, pfizer weaknesses 2021, pfizer strengths.